Down syndrome (trisomy 21) thymuses have a decreased proportion of cells expressing high levels of TCRα,β and CD3
- 1 June 1990
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 55 (3), 453-467
- https://doi.org/10.1016/0090-1229(90)90131-9
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Alterations in thymocyte subpopulations in Down's syndrome (trisomy 21)Clinical Immunology and Immunopathology, 1988
- Ontogeny of T-cell receptor gene expressionTrends in Genetics, 1987
- The Lymphocyte Function Associated LFA-1, CD2, and LFA-3 Molecules: Cell Adhesion Receptors of the Immune SystemAnnual Review of Immunology, 1987
- Expression of antigen-specific, major histocompatibility complex-restricted receptors by cortical and medullary thymocytes in situCell, 1985
- Mouse Trisomy 16: An Animal Model of Human Trisomy 21 (Down Syndrome)aAnnals of the New York Academy of Sciences, 1985
- Immune interferon: a pleiotropic lymphokine with multiple effectsImmunology Today, 1985
- Mouse trisomy 16 as an animal model of human trisomy 21 (Down syndrome): Production of viable trisomy 16 ↔ diploid mouse chimerasDevelopmental Biology, 1984
- The differentiation and function of human T lymphocytesCell, 1980
- STRESS DEFICIENCY OF THE T-LYMPHOCYTE SYSTEM EXEMPLIFIED BY DOWN SYNDROMEThe Lancet, 1977
- MORTALITY AND LIFE‐TABLE IN DOWN'S SYNDROMEActa Paediatrica, 1975